AffiNANOTECH® Farletuzumab ecteribulin
CAT# AFG-MCX-0411
Size: 100 mg
Availables Sizes: 1 mg, 5 mg, 10 mg, 50 mg, 100 mg.
Overview
Farletuzumabecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-humanfolate receptor alpha (FRA) antibodyFarletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin.Farletuzumabecteribulin has a agent-to-antibody ratio of 4.0.Farletuzumabecteribulin is highly cytotoxic to FRA-positive cells in vitro.Farletuzumabecteribulin has potent antitumor activity.
Isotype
N/A.
Species
N/A.
Target
N/A.
Appearance
Liquid.
Shipping Conditions
Dry Ice.
Storage Conditions
Store the product under the recommended conditions in the Certificate of Analysis.